|Mr. Bruke Seyoum Alemu Dipl.-Ing.||Chairman of Mgmt. Board & Chief Exec. Officer||335k||N/A||51|
|Mr. Marek Hahn||CFO & Member of Mgmt. Board||237k||N/A||43|
|Nanette Hüdepohl||Head of Corp. Communications||N/A||N/A||N/A|
aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany and the United States. The company offers LOQTEQ, an anatomical angular stable plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. It also offers bone substitutes, including Artosal, a synthetic osteoconductive bone substitute; Cerabone, a ceramic bone substitute; OsteoCem, a calcium phosphate cement; Osnatal, a high-quality human bone allograft; PerOssal, a fully synthetic bone substitute and carrier material; and Calcifix, a calcium phosphate cement, as well as collagen fleeces. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
AAP Implantate AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.